![]() |
市場調查報告書
商品編碼
1466567
月經藥物市場:按類型、治療方法、分銷管道和最終用戶分類 - 全球預測 2024-2030Dysmenorrhea Treatment Market by Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), Treatment (Medication, Surgery, Therapeutics), Distribution Channel, End-Users - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年月經治療市場規模為71.6億美元,2024年達78億美元,預計2030年將達130.9億美元,複合年成長率為8.98%。
月經藥物是指控制和緩解與月經和月經疼痛相關的疼痛和不適的治療方法。月經是一種常見疾病,其特徵是在月經月經之前發生腹部絞痛,影響很大一部分月經個體。經月經的治療方法旨在減輕疼痛、改善生活品質並盡量減少對日常生活的干擾。同時,人們對婦女生殖健康的認知不斷提高,政府支持婦女保健機構的措施和計畫也為擴大月經相關治療做出了重大貢獻。醫療保健營業單位增加的臨床試驗和大量投資也有助於月經藥物和診斷方法的大規模供應。然而,缺乏與月經止痛藥物相關的報銷政策和嚴格規定,給經月經藥物提供者帶來了重大挑戰。公司不斷降低治療成本並投資新藥研究工作,以在不斷變化的市場環境中保持競爭力。此外,月經治療的最新進展以及穿戴式科技和數位醫療服務的日益採用也常常有助於月經藥物未來的擴張。此外,由人工智慧和機器學習提供支援的資料主導的見解可以幫助制定個人化的治療計劃並確定可導致經月經醫學新治療性介入的模式。
主要市場統計 | |
---|---|
基準年[2023] | 71.6億美元 |
預測年份 [2024] | 78億美元 |
預測年份 [2030] | 130.9億美元 |
複合年成長率(%) | 8.98% |
原發性經痛類型的廣泛發生和疼痛緩解管理的廣泛需求
原發性經痛是由子宮收縮和月經期間Gland釋放引起的,高達 90% 的女性都會經歷這種情況。月經的主要治療方法是緩解疼痛和控制疼痛。其他治療方法包括幫助調節荷爾蒙水平的口服避孕藥、緩解肌肉緊張的熱療以及運動和減輕壓力等生活方式的改變。次發性月經是由子宮內膜異位症、發炎或子宮肌瘤等潛在疾病引起的月經痛。治療次發性月經的藥物需要專注於緩解症狀,同時解決疼痛的根本原因。續發性月經的治療方法取決於具體的疾病。子宮內膜異位症的治療包括荷爾蒙療法、腹腔鏡手術等外科手術和發炎藥物。如果發炎是續發性月經的根本原因,通常會開抗生素來治療感染疾病。
治療 以子宮切除術治療永久緩解月經
藥物往往是治療月經的首選。非類固醇消炎劑(NSAID),例如Ibuprofen和萘普生,可以有效減輕與月經來潮相關的疼痛和發炎。這些藥物可在櫃檯購買或由醫療保健專業人員處方。手術介入治療僅限於因子宮內膜異位症或子宮肌瘤等潛在疾病而加劇經月經的患者。腹腔鏡手術是微創手術,可以有效去除引起疼痛的沾黏和肌瘤。在極端情況下,子宮切除術(包括切除子宮)可以永久緩解月經。此外,心理介入有助於解決與月經相關的心理困擾並提高整體應對能力。最常使用的心理療法包括認知行為療法(CBT)、放鬆技巧(深呼吸、漸進式肌肉放鬆)和生物回饋療法(監測心率變異性、肌肉張力和皮膚溫度等生理過程)。此外,各種非藥理學的處置方法越來越受歡迎,因為它們在控制月經症狀方面具有潛在的好處,而且不會引起明顯的副作用。很少有替代療法,例如針灸、經皮神經電刺激 (TENS)、芳香療法、瑜伽和營養補充,可以為那些尋求非藥物方法來控制月經症狀的患者提供多種選擇。患者提供全面的護理選擇。
分銷管道:藥品和止痛貼片的便利性、自由裁量權和有競爭力的價格正在推動人們對網路藥局的偏好。
在月經的治療中,醫院藥局對於立即為患者提供正確的藥物至關重要。醫院藥房出售治療各種類型月經的非處方藥 (OTC) 和處方成藥,包括非類固醇消炎劑(NSAID)、鎮痛藥、解痙藥和荷爾蒙藥物,包括口服避孕藥。月經藥局因其便利性、可自由裁量權和有競爭力的價格而越來越受歡迎。此線上平台提供各種產品,包括傳統成藥和草藥補充品和熱貼等替代療法。網路藥局是重視隱私或居住在無法進入實體店的偏遠地區的人們的最愛。零售藥局仍然是月經藥物的重要分銷管道,因為它們可以輕鬆獲得藥物,而無需事先預約醫療保健專業人員。這些藥房備有各種非處方藥,包括Ibuprofen、萘普生和阿斯匹靈。零售藥局迎合那些喜歡與藥劑師面對面接觸以獲得個人化建議和建議的消費者。
最終用戶:由於易於獲取和成本效益,家庭護理領域擴大採用月經藥物
在居家照護領域,最終使用者更喜歡易於取得且具成本效益的治療方案來控制月經症狀。這包括非類固醇消炎劑(NSAID)、Ibuprofen和萘普生等成藥)以及熱療和草藥補充品等自然療法。家庭護理還包括瑜伽、針灸和按摩等替代療法,這些療法在緩解月經痛方面已顯示出良好的效果。最終用戶更喜歡醫院來治療嚴重月經,因為它需要更多的重症監護和先進的干涉措施。對於患有導致嚴重月經症狀的潛在婦科疾病的患者,也可能建議進行手術治療。子宮內膜異位症相關的月經痛可以由醫院的專業婦科醫生透過腹腔鏡手術治療。專科診所為最終使用者尋求了解女性健康問題的醫療專業人員(例如婦科醫生、生殖內分泌科醫生和骨盆疼痛專家)的專門治療提供服務。這些診所提供個人化的治療計劃,包括處方藥、荷爾蒙療法、物理治療和心理諮詢。
區域洞察
在美洲國家,包括美國和加拿大,很大一部分女性人口經歷月經疼痛,包括月經。隨著這些國家對婦女健康問題的認知不斷提高,人們正在做出各種努力來研究和開發針對這種情況的有效治療方法。歐盟 (EU) 國家擁有先進的醫療保健系統,優先考慮女性健康,並為經月經治療方案的研究提供大量資金。例如,歐洲藥品管理局(EMA)已在歐洲國家核准了多種針對緩解月經疼痛的藥物。此外,中國、日本和印度是亞太地區月經藥物的主要市場,因為這些國家有大量遭受月經痛的女性。在這些國家,傳統醫學在解決月經發揮著重要作用。此外,該地區正在進行研究,以探索針灸和艾灸等替代療法治療月經的有效性。在日本,傳統醫學和現代醫學結合的方法被用來解決女性的健康問題,並開立洛索洛芬等專利藥物來緩解月經疼痛。在印度,人們對婦女健康問題的認知不斷提高,導致對月經衛生管理的投資增加,並增加了獲得負擔得起的醫療保健的機會。根據文化因素、醫療基礎設施和對女性健康問題的認知,全球對有效月經治療的需求因地區而異。研究和開發的創新為推進月經治療藥物的選擇提供了有希望的機會。
FPNV定位矩陣
FPNV定位矩陣對於評估月經治療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對經月經藥物市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.月經治療藥物市場規模及預測是多少?
2.月經治療藥物市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3.月經治療藥物市場的技術趨勢和法規結構是什麼?
4.月經治療藥物市場主要廠商的市場佔有率為何?
5.進入經月經藥市場合適的型態和策略手段是什麼?
[189 Pages Report] The Dysmenorrhea Treatment Market size was estimated at USD 7.16 billion in 2023 and expected to reach USD 7.80 billion in 2024, at a CAGR 8.98% to reach USD 13.09 billion by 2030.
Dysmenorrhea treatment refers to the therapeutic approaches for managing and alleviating the pain and discomfort associated with dysmenorrhea or menstrual cramps. Dysmenorrhea is a prevalent condition affecting a significant proportion of menstruating individuals, characterized by painful abdominal cramping that occurs during or before their menstrual periods. The treatments for treating dysmenorrhea aim to reduce the pain, improve quality of life, and minimize disruption to daily activities. Meanwhile, the rising awareness about women's reproductive health and government initiatives & programs supporting healthcare facilities for women contribute significantly to the expansion of dysmenorrhea-related treatments. The increasing number of clinical trials and huge investments by healthcare entities have also contributed to the large-scale dysmenorrhea treatments & diagnosis. However, the lack of reimbursement policies and strict regulations associated with the drugs for menstrual pains is a significant challenge for dysmenorrhea treatment providers. Companies are continuously working toward cutting treatment costs and investing in research activities for novel medications to remain competitive in this evolving market landscape. Moreover, the recent advancements in the therapy of dysmenorrhea and increasing adoption of wearable technology along with digital health services are frequently contributing to the future expansion of dysmenorrhea treatment. Additionally, harnessing data-driven insights using artificial intelligence and machine learning can also aid in developing personalized treatment plans and identifying patterns leading to new therapeutic interventions in dysmenorrhea treatments.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 7.16 billion |
Estimated Year [2024] | USD 7.80 billion |
Forecast Year [2030] | USD 13.09 billion |
CAGR (%) | 8.98% |
Type: Wide occurrence of primary dysmenorrhea and extensive need for pain relief management
Primary dysmenorrhea is experienced by up to 90% of women which is caused by uterine contractions and prostaglandin release during menstruation. The need for primary dysmenorrhea treatment mainly revolves around pain relief and management. Additional treatments include oral contraceptives that help regulate hormone levels, heat application to ease muscle tension, and lifestyle modifications such as exercise and stress reduction. Secondary dysmenorrhea is menstrual pain caused by an underlying medical condition, including endometriosis, pelvic inflammatory disease, or uterine fibroids. The need for secondary dysmenorrhea treatment focuses on addressing the root cause of the pain while also providing symptom relief. The treatment options for secondary dysmenorrhea vary depending on the specific medical condition. Endometriosis treatments may include hormonal therapy, surgical interventions such as laparoscopic surgery, and anti-inflammatory medications. The cases having pelvic inflammatory disease is the underlying cause of secondary dysmenorrhea, antibiotics are often prescribed to treat the infection.
Treatment: Adoption of hysterectomy treatment to provide permanent relief from dysmenorrhea
Medications are often the first line of treatment for dysmenorrhea. Nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen and naproxen, effectively reduce pain and inflammation associated with menstrual cramps. These medications are purchased over the counter or prescribed by a healthcare professional. Surgical intervention treatment is reserved for patients with severe dysmenorrhea caused by underlying conditions such as endometriosis or uterine fibroids. Laparoscopic surgery is minimally invasive and can effectively remove adhesions or fibroids causing the pain. In extreme cases, a hysterectomy, which is the removal of the uterus, may be performed to provide permanent relief from dysmenorrhea. Moreover, psychological interventions can be beneficial in addressing the emotional distress linked to dysmenorrhea and enhancing overall coping abilities. Most used psychological therapies include cognitive behavioral therapy (CBT), relaxation techniques (deep breathing, progressive muscle relaxation), and biofeedback (monitoring physiological processes such as heart rate variability, muscle tension, or skin temperature). Furthermore, various non-pharmacological approaches have gained popularity due to their potential benefits in managing dysmenorrhea symptoms without causing significant side effects. Few alternative treatments, including acupuncture, transcutaneous electrical nerve stimulation (TENS), aromatherapy, yoga, and dietary supplements, offer a variety of options for individuals seeking non-pharmacological methods to manage dysmenorrhea symptoms and provide comprehensive care options for patients experiencing menstrual pain.
Distribution Channel: Growing preference for online pharmacies due to their convenience, discreteness, and competitive pricing of medications and pain relief patches
In treating dysmenorrhea, hospital pharmacies are crucial in providing patients with immediate and appropriate medication. Hospital pharmacies often have a wide range of over-the-counter (OTC) and prescription medications to treat various types of dysmenorrhea, including nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, antispasmodics, and hormonal treatments, including oral contraceptives. Online pharmacies are increasingly popular for purchasing dysmenorrhea treatments due to their convenience, discreteness, and competitive pricing. Online platforms offer a variety of products, including traditional OTC medications and alternative remedies such as herbal supplements and heat patches. The preference for online pharmacies is higher among those seeking privacy or living in remote areas with limited access to physical retail outlets. Retail pharmacies remain an essential distribution channel for dysmenorrhea treatments as they offer easy access to medication without needing a prior appointment with a healthcare professional. These pharmacies stock various OTC medications, including ibuprofen, naproxen, and aspirin. Retail pharmacies cater to consumers preferring face-to-face interaction with pharmacists for personalized advice and recommendations.
End-Users: Increasing adoption of dysmenorrhea treatment in the homecare segment as it is easily accessible and cost-effective
In the homecare sector, end-users prefer easily accessible and cost-effective treatment options to manage dysmenorrhea symptoms. These include over-the-counter (OTC) medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), ibuprofen, and naproxen, and natural remedies, including heat therapy and herbal supplements. Homecare also involves alternative therapies such as yoga, acupuncture, and massage that have shown promising results in alleviating menstrual pain. End-users prefer hospitals in need of more intensive care or advanced interventions for treating severe cases of dysmenorrhea. Surgical treatments may also be recommended in patients with underlying gynecological conditions contributing to severe dysmenorrhea symptoms. Endometriosis-related menstrual pain can be treated in laparoscopic surgery by specialized gynecological surgeons in hospitals. Specialty clinics cater to end-users seeking specialized care from healthcare professionals with expertise in women's health issues, such as gynecologists, reproductive endocrinologists, and pelvic pain specialists. These clinics offer personalized treatment plans, including prescription medications, hormonal therapy, physical therapy, or psychological counseling.
Regional Insights
In American countries, including the United States and Canada, a large percentage of the female population experiences menstrual cramps, including dysmenorrhea. These countries witness various efforts to research and develop effective treatments for this condition with greater awareness of women's health issues. European Union countries have advanced healthcare systems that prioritize women's health, leading to significant funding for research on dysmenorrhea treatment options. For instance, the European Medicines Agency (EMA) has approved various medications targeting menstrual pain relief across European countries. Furthermore, China, Japan, and India are key markets within the Asia-Pacific region for dysmenorrhea treatment due to their large populations of women experiencing menstrual pain. Traditional medicine plays a crucial role in addressing dysmenorrhea in these countries. Moreover, research initiatives in this region explore the efficacy of alternative therapies, such as acupuncture and moxibustion, in treating dysmenorrhea. In Japan, a mix of traditional and modern medical approaches is adopted to address women's health issues, with patented medications such as Loxoprofen being prescribed for menstrual pain relief. India has observed an increase in investment in menstrual hygiene management and access to affordable healthcare with its growing awareness about women's health issues. The need for effective dysmenorrhea treatments worldwide varies across regions based on cultural factors, healthcare infrastructure, and awareness about women's health issues. Innovations in research and development provide promising opportunities for advancements in dysmenorrhea treatment options.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Dysmenorrhea Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Dysmenorrhea Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Dysmenorrhea Treatment Market, highlighting leading vendors and their innovative profiles. These include AA Pharma Inc., Abbott Laboratories, AbbVie Inc., Alfa Pharma GmbH, Alvogen, Inc., ASKA Pharmaceutical Co., Ltd., Bayer AG, Comforte Cream by PMS4PMS, LLC, Cora Life by LYV Life, Inc., Cumberland Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Endo Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Ferring B.V., Gedeon Richter Plc., GlaxoSmithKline PLC, Haleon PLC, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., LGM Pharma, Livia by iPulse Medical Ltd., Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Micro Labs Limited, Myoovi, Myovant Sciences by Sumitovant Biopharma, Inc., Novartis AG, Ovira, Perrigo Company PLC, Pfizer Inc., Rael, Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited., Teva Pharmaceutical Industries Ltd., and Viatris Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Dysmenorrhea Treatment Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Dysmenorrhea Treatment Market?
3. What are the technology trends and regulatory frameworks in the Dysmenorrhea Treatment Market?
4. What is the market share of the leading vendors in the Dysmenorrhea Treatment Market?
5. Which modes and strategic moves are suitable for entering the Dysmenorrhea Treatment Market?